NRSN ▼ -2.4% - NeuroSense Therapeutics Ltd. $NRSN - Form 6K - signed a strategic collaboration agreement with an advisor to advance a revenue-generating supply of PrimeC, its lead therapeutic candidate for ALS, to eligible patients through a licensed clinical treatment center in a state in the U.S. 26-OCT-2026 12:49 PM ET